U.S., Feb. 11 -- An application to own the trademark for 'LYZERTRI' has been filed on Jul. 18, 2024.
Owner(s):
Johnson & Johnson; One Johnson & Johnson Plaza, , New Jersey
Goods and/or Services:
For: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers
Class(es): 005, 006, 018, 044, ...